Skip to main content
All lobbying filings

THE UNITED STATES PHARMACOPEIAL CONVENTION

THE UNITED STATES PHARMACOPEIAL CONVENTION filed a Q1 report for THE UNITED STATES PHARMACOPEIAL CONVENTION on April 21, 2025.

Lobbying for THE UNITED STATES PHARMACOPEIAL CONVENTION

All filings by THE UNITED STATES PHARMACOPEIAL CONVENTION · Everything THE UNITED STATES PHARMACOPEIAL CONVENTION has reported

 Filing · LD-2 quarterly report Q1 report
Reporting period
1st Quarter 2025
Jan 1 - Mar 31 · Posted Apr 21, 2025
Expenses
$70,000
What this organization spent lobbying with its own staff. Reported using IRS section 6033(b)(8) definitions (method B): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.
Client based in
Maryland

Official filing document

 Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 1
Health Issues

Issues regarding drug shortages and pharmaceutical supply chain resilience.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem